Vascular Inflammation: From Target Molecules to Therapeutic Approaches

© 2022 by the authors; CC BY-NC-ND license

postoperative delirium; biomarker; vascular inflammation; elective surgery; cardiac surgery; glycocalyx; CCL2; MCP-1; microRNAs; let-7; stroke; cardiovascular; inflammation; coronary artery disease; vasculitis; inflammatory diseases; systemic vasculitis; molecular target; novel treatment; PCSK9; cardiovascular disorders; low density lipoprotein receptor; cholesterol; polymorphisms; monoclonal antibodies; acute respiratory distress syndrome; ultrasound; microbubbles; endothelial cells; vascular leak; drug and gene delivery; Na⁺ salt; hypertension; Na⁺ salt sensitive hypertension; vascular endothelial cells; vascular smooth muscle cells; glycocalyx; Na/Ca exchanger; Na/H exchanger; SARS-CoV-2; COVID-19; thromboembolism; ACE inhibition; pathophysiology; apurinic/apyrimidinic endonuclease-1/redox factor-1; 17β-estradiol; estrogen receptor; endothelial cells; calcium; exosome; endothelium; hydrogen sulfide; inflammation; therapeutic target; SARS-CoV-2; COVID-19; vasculitis; systemic lupus erythematosus; lupus vasculitis; small vessel vasculitis; apurinic/apyrimidinic endonuclease-1/redox factor-1; mucocutaneous lymph node syndrome; vasculitis; adventitial inflammation; arteriovenous fistula; chronic inflammation; early thrombosis; fibrosis; maturation; maturation failure; perivascular cuffing; vascular inflammation; peripheral arterial disease (PAD); chronic limb-threatening ischemia (CLTI); GHAS trial; TNF-α; hsCRP; neutrophil-to-lymphocyte ratio (NLR); NOX4; NOS3 (eNOS); VEGFA